Sex: F
Vaccine: COVID19
Symptoms: Angioedema, Body temperature, Breast pain, Breast swelling, Breast tenderness
Clinical narrative: I also had angioedema in my lip only; dose 3 (booster) on 07Oct2021; dose 3 (booster) on 07Oct2021; what has been reported has been lymph node swelling, this is larger then a small lymph node.; noticed swelling, size of fist under her left armpit  that goes over across to her chest at top of her breast; the tenderness and swelling in my arm; the tenderness and swelling in my arm; sore/it's on the side of my arm pit and across the breast area and a little bit under the breast area; top of the area of the arm pit and it went across near the chest wall at top of her breast, swelling is tender, states it is about the size of her fist; top of the area of the arm pit and it went across near the chest wall at top of her breast, swelling is tender, states it is about the size of her fist; This is a spontaneous report from a contactable consumer (patient) reported for herself. A female patient of an unspecified age received third dose of BNT162B2 (COMIRNATY, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on 07Oct2021 at 14:00 pm (age at vaccination was unknown) as dose 3 (booster), single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date (age at vaccination was unknown) as dose 1, single and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date (age at vaccination was unknown) as dose 2, single for COVID-19 immunization and experienced some side effects of fever/low grade fever of 100.5 and chills/rolling chills after second dose. On an unspecified date in Oct2021, within 48 to 72 hours, the patient noticed swelling, size of fist under her left armpit that goes over across to her chest at top of her breast and she wanted to know if it was normal. She also said it was tender and swollen/swelling under left arm pit. It was not her my arm pit, it was on the side of her arm pit and across the breast area and a little bit under the breast area. It was in the upper armpit, tender, sore and swollen and you can see it was swollen, not a hard ball but you see a size of her fist swelling, it was to the left side of the outer breast. She knew what had been reported had been lymph node swelling, this was larger then a small lymph node. It was bigger then a lymph node. On an unspecified date in Oct2021, on the night of the second day and into the morning of the third day after the booster shot, she noticed a swelling under the left arm, where she got the shot, not in the arm pit but in the top of the area of the arm pit and it went across near the chest wall at top of her breast, swelling was tender, stated it was about the size of her fist, went to her urgent care and they said it appeared as if it was a swollen lymph nodes, gland, so that was one side effect. She asked if that was normal. She asked if this had been reported and also been documented. On an unspecified date, the patient had angioedema in her lip only. She asked if there were any reports of this. She was concerned about the tenderness and swelling in her arm. She did not know if she was going to the emergency room now, she wanted to know if this swelling under her arm across her chest the size of her chest about 48-72 hours after the booster, had not subsided and was very tender. The outcome of the event swelling was not resolved. The outcome of the other events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.